Silence Therapeutics plc (SLNCF)
OTCMKTS
· Delayed Price · Currency is USD
2.000
+0.250 (14.29%)
Mar 9, 2026, 9:49 AM EST
Silence Therapeutics Market Cap
Silence Therapeutics has a market cap or net worth of $294.27 million as of March 9, 2026. Its market cap has increased by 30.12% in one year.
Market Cap
294.27M
Enterprise Value
209.31M
Revenue
559.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$2.00
Market Cap Chart
Since September 8, 2020, Silence Therapeutics's market cap has decreased from 538.37M to 294.27M, a decrease of -45.34%. That is a compound annual growth rate of -10.40%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CytoDyn | 296.04M |
| Northwest Biotherapeutics | 360.56M |
| Vaxart | 177.30M |
| HST Global | 88.19M |
| BioStem Technologies | 87.58M |
| Nuo Therapeutics | 60.36M |
| Vicapsys Life Sciences | 48.56M |
| Cell Source | 48.33M |